July 23, 2025 - 04:07

In a recent statement, ICE Director Todd Lyons expressed significant concerns regarding the potential misuse of artificial intelligence technology, particularly in relation to the safety of immigration officers. He highlighted that advancements in AI could enable "fringe organizations" to uncover the identities of agents, putting them at increased risk. This warning comes in the context of the proposed VISIBLE Act legislation, which aims to enhance protections for law enforcement personnel.
Lyons pointed out that there has been an alarming 830% increase in assaults on immigration officers, underscoring the urgent need for measures to safeguard their identities and operational security. The integration of AI in various sectors has raised ethical questions, and Lyons emphasized the importance of addressing these challenges proactively to ensure the safety of agents working in increasingly hostile environments.
As discussions surrounding the VISIBLE Act continue, the implications of AI technology on law enforcement practices remain a critical topic for policymakers and security experts alike.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...